The Chief Executive of the UK’s Association of the British Pharmaceutical Industry (ABPI), Richard Torbett, has stressed the importance of investment in research in response to the Queen’s Speech delivery.
“The response to the pandemic has shown just how critical the UK’s pharmaceutical industry is to our country’s future and the Queen’s Speech has set the ambition for the UK to lead the world in life sciences,” he said. “Investment in research and skills must support this vision. Plans to boost R&D funding and improve education and training can support our members make the UK a life sciences superpower.”
There were several key announcements in the Queen’s Speech for the life sciences sector. They include: Continuation of the Covid-19 vaccination rollout, supported by extra funding for the NHS, an ambition for the UK to lead the world on life sciences, and secure jobs and investment across the country with the fastest ever increase in funding for research and a new research agency.
